Swansea based Medical Connections Limited has successfully completed a management buy-out.

The medical imaging software toolkit company was founded by the late Doctor David Harvey in 1998. As a consultant radiologist, he was passionate about the development of healthcare IT to deliver better patient care.  The Company is a well-established medical imaging toolkit provider and has been recognised as a global leader in facilitating the development of healthcare IT systems to promote interoperability.

Birmingham-based Linear Diagnostics Limited (LDL) has secured £2m of investment from MEIF and other investors to develop new platform technology for medical diagnostic testing.

GP Bullhound acted as exclusive financial advisor to Jellyfish on the strategic investment by Fimalac Group which will also see Tradelab (part of Fimalac Group) integrated into Jellyfish. The deal will put the value of the new enlarged Jellyfish at circa £500m.

Flarin Holdings Limited has completed its first round of fund-raising by IW Capital. Flarin Holdings was recently demerged from Infirst Healthcare Limited in order to provide greater focus on the rapid commercialisation of Flarin.  Flarin is a unique and patent protected lipid formulated ibuprofen which at a dose of 1200 mg/day has shown to be as effective as 2400mg/day of standard liquid ibuprofen capsules in patients with acute joint pain. Flarin’s unique lipid formulation also helps to shield the stomach from damage.

Many years ago, when I first joined the wine trade, the number of grape varieties available to the consumer was limited. It was a rarity to see them mentioned, even on the back label of a bottle of wine.

Santander has bought a majority stake in UK-based Fintech company Ebury for £350m. The bank now holds 50.1 percent in Ebury, a trade and foreign exchange facilitator for small and medium-sized companies. The Angel CoFund first invested in Ebury in its seed round in 2012 and has invested £1.3m in total across four funding rounds. The firm retains a shareholding of Ebury.

Foresight Group LLP has opened its fifth regional UK office, located in historic George Street in Edinburgh.

PRIVATE equity house WestBridge has further expanded its team with the appointment of Rebecca Sinclair as Investment Executive.

BGF, the UK and Ireland’s most active investor in growing businesses, has exited its investment in Thames Technology, one of the UK’s largest manufacturers and designers of payment, loyalty and gift cards. The business has been acquired by Paragon ID, the Paris-listed provider of identification and traceability solutions.

Israeli precision agriculture startup Agritask, which has been operating in bootstrap mode till recently, has completed an $8.5M Series A financing round, led by the InsuResilience Investment Fund and co-invested by Barn Investimentos. The InsuResilience Investment Fund was set up on behalf of the German government by KfW and is managed by Swiss-based impact investment manager BlueOrchard Finance. Barn Investimentos is a Brazilian early stage VC Investor focusing on high growth companies in ag-tech and in other industries.

Oxford Drug Design Limited (ODD), a biotechnology company with a proprietary computational and machine learning platform, has raised a combined £2.2M in funding from the Angel CoFund (ACF), o2h Ventures and other new investors, and grant funding from the UK Department of Health and Social Care (DHSC)'s UK-China research competition. This brings the firm’s total amount of grant and equity funding raised in 2019 to over £9M.

New research from Nucoro, a B2B fintech providing Wealth Management as a Service Solutions, reveals 57% of wealth managers are having to turn away clients because they fall below their service threshold. The average wealth manager turns away 72 clients every year, with 33% of respondents claiming they have had to turn away more potential clients in the last 12 months than they did three years ago. Just 2% of wealth managers said they are turning away fewer potential clients than in the past, while 49% say that the number hasn’t changed.